Elekta (OTCMKTS:EKTAY – Get Free Report) and QT Imaging (NASDAQ:QTI – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.
Valuation & Earnings
This table compares Elekta and QT Imaging”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Elekta | $1.78 billion | 1.28 | -$55.38 million | ($0.12) | -51.58 |
| QT Imaging | $26.43 million | 1.11 | -$21.08 million | ($1.57) | -1.36 |
QT Imaging has lower revenue, but higher earnings than Elekta. Elekta is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Elekta and QT Imaging’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Elekta | -2.38% | 13.47% | 3.84% |
| QT Imaging | -77.25% | -1,202.69% | -46.76% |
Risk & Volatility
Elekta has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of 0.05, indicating that its stock price is 95% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Elekta and QT Imaging, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Elekta | 0 | 1 | 0 | 0 | 2.00 |
| QT Imaging | 1 | 1 | 3 | 0 | 2.40 |
QT Imaging has a consensus target price of $8.50, indicating a potential upside of 298.31%. Given QT Imaging’s stronger consensus rating and higher possible upside, analysts plainly believe QT Imaging is more favorable than Elekta.
Institutional & Insider Ownership
24.2% of QT Imaging shares are owned by institutional investors. 41.3% of Elekta shares are owned by insiders. Comparatively, 25.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
Elekta beats QT Imaging on 8 of the 14 factors compared between the two stocks.
About Elekta
-logo-1200x675.png?v=20240604134456){kind=logo}
Elekta is a Swedish medical technology company that develops equipment and software for radiation therapy and other treatments used in cancer care and neurosurgery. Founded in 1972 by neurosurgeon Lars Leksell, the company builds on his work in stereotactic radiosurgery. Its offerings include linear accelerators for external-beam radiation therapy, systems for stereotactic radiosurgery and brachytherapy, and software that helps healthcare providers plan and manage treatment. Elekta’s technologies are used by hospitals and clinics to deliver care for cancer and certain neurological conditions.
About QT Imaging
QT Imaging Holdings, Inc. (NASDAQ:QTI) is a medical technology company that develops advanced ultrasound-based imaging systems. Its technology is designed to create three-dimensional images of human tissue without using ionizing radiation. The company’s principal product is the QTscan, an automated breast-imaging system that uses sound waves to capture images without breast compression. The system is intended to support breast imaging and may be particularly relevant for evaluating breast tissue that can be difficult to assess with conventional mammography.
Receive News & Ratings for Elekta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta and related companies with MarketBeat.com's FREE daily email newsletter.
